Free Trial
OTCMKTS:ASPCF

Acerus Pharmaceuticals (ASPCF) Stock Price, News & Analysis

Acerus Pharmaceuticals logo
$0.22
0.00 (0.00%)
(As of 07/21/2023)

About Acerus Pharmaceuticals Stock (OTCMKTS:ASPCF)

Key Stats

Today's Range
$0.22
$0.22
50-Day Range
$0.22
$0.22
52-Week Range
$0.22
$8.16
Volume
N/A
Average Volume
1,500 shs
Market Capitalization
$1.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men's health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada.

Receive ASPCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acerus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ASPCF Stock News Headlines

Banking failure dead ahead
If you missed it, my emergency election broadcast is now available - but will be removed soon
Acerus Reports Third Quarter 2022 Financial Results
Acerus Announces Initiation of Strategic Review
See More Headlines

ASPCF Stock Analysis - Frequently Asked Questions

Acerus Pharmaceuticals' stock was trading at $0.22 at the start of the year. Since then, ASPCF stock has increased by 0.0% and is now trading at $0.22.
View the best growth stocks for 2024 here
.

Acerus Pharmaceuticals shares reverse split before market open on Friday, April 29th 2022. The 1-200 reverse split was announced on Friday, April 29th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of ASPCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
10/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:ASPCF
CIK
N/A
Employees
14
Year Founded
N/A

Profitability

Net Income
$-33,820,000.00
Net Margins
-924.33%
Pretax Margin
-924.33%

Debt

Sales & Book Value

Annual Sales
$2.12 million
Book Value
($3.38) per share

Miscellaneous

Free Float
N/A
Market Cap
$1.70 million
Optionable
Not Optionable
Beta
0.69
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:ASPCF) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners